论文部分内容阅读
心脑血管病是危害人类生命和健康的主要疾病。造成心脑血管疾病的主要原因之一是由于血管内形成了血栓,因此,寻找一种可以溶解血栓和预防血栓形成的有效药物是人们期待已久的事,中国科学院生物物理所科研人员以传统中医药学为依据,采用现代生物化学技术,历经10多年的艰辛研究,制成了具有直接溶栓及间接溶栓双重功效的国家二类西药蚓激酶胶囊。1992年获卫生部颁发的新药证书,1995年获准字号批文。该项成果获1993年中国科学院科技
Cardiovascular and cerebrovascular diseases are the major diseases endangering human life and health. One of the major causes of cardiovascular and cerebrovascular diseases is due to the formation of thrombus in the blood vessels. Therefore, looking for an effective drug that can dissolve blood clots and prevent thrombosis is a long-awaited event. Researchers at the Institute of Biophysics, Chinese Academy of Sciences, Chinese medicine as the basis, the use of modern biochemical technology, after more than 10 years of hard research, made with direct thrombolytic and indirect thrombolytic double effect of the national second-class lumbrokinase capsules. In 1992 by the Ministry of Health issued a new drug certificate, was approved in 1995 font size approval. This achievement won the 1993 Chinese Academy of Science and Technology